Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent - TAXUS IV: Results Through 5 Years


The goal of the TAXUS IV trial was to evaluate the efficacy of the slow-rate release polymer-based paclitaxel-eluting stent (PES) compared with a bare-metal stent (BMS) in patients with single de novo coronary lesions.